UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

Blood, 2013-06, Vol.121 (26), p.5113-5123

2013

Volltextzugriff (PDF)

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

Blood, 2013-08, Vol.122 (7), p.1316-1324

2013

Volltextzugriff (PDF)

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

Blood, 2013-05, Vol.121 (18), p.3745-3758

2013

Volltextzugriff (PDF)

TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells

Blood, 2015-12, Vol.126 (26), p.2781-2789

2015

Volltextzugriff (PDF)

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

Blood, 2011-11, Vol.118 (20), p.5689-5696

2011

Volltextzugriff (PDF)

Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation

Blood, 2008-11, Vol.112 (10), p.3974-3981

2008

Volltextzugriff (PDF)

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

Blood, 2004-03, Vol.103 (6), p.2003-2008

2004

Volltextzugriff (PDF)

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

Blood, 2008-06, Vol.111 (11), p.5403-5410

2008

Volltextzugriff (PDF)

Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation—a randomized double-blind placebo-controlled study

Blood, 2006-03, Vol.107 (5), p.1800-1805

2006

Volltextzugriff (PDF)

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

Blood, 2002-03, Vol.99 (6), p.1978-1985

2002

Volltextzugriff (PDF)

Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells

Blood, 2007-11, Vol.110 (9), p.3472-3479

2007

Volltextzugriff (PDF)

Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells

Blood, 2006-12, Vol.108 (12), p.3691-3699

2006

Volltextzugriff (PDF)

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

Blood, 2002-02, Vol.99 (4), p.1159-1164

2002

Volltextzugriff (PDF)

Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy

Blood, 2008-02, Vol.111 (4), p.1816-1819

2008

Volltextzugriff (PDF)

CMV: a warrior against leukemia?

Blood, 2013-08, Vol.122 (7), p.1101-1102

Ljungman, Per

2013

Volltextzugriff (PDF)

Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation : Effect of patient age and donor leukocyte infusions

Blood, 1999-01, Vol.93 (2), p.467-480

1999

Volltextzugriff (PDF)

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

Blood, 2003-10, Vol.102 (8), p.3060-3067

2003

Volltextzugriff (PDF)

Cytomegalovirus pp65 Antigenemia-Guided Early Treatment With Ganciclovir Versus Ganciclovir at Engraftment After Allogeneic Marrow Transplantation: A Randomized Double-Blind Study

Blood, 1996-11, Vol.88 (10), p.4063-4071

1996

Volltextzugriff (PDF)

Pharmacotherapy versus T lymphocytes for CMV

Blood, 2013-05, Vol.121 (18), p.3544-3545

Heslop, Helen E.

2013

Volltextzugriff (PDF)

Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants

Blood, 2002-04, Vol.99 (8), p.3050-3056

2002

Volltextzugriff (PDF)

Antiviral cell therapy: is this the future?

Blood, 2013-06, Vol.121 (26), p.5108-5109

Gea-Banacloche, Juan C.

2013

Volltextzugriff (PDF)

Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening

Blood, 2006-12, Vol.108 (13), p.4275-4282

2006

Volltextzugriff (PDF)

A Comparison of Filtered Leukocyte-Reduced and Cytomegalovirus (CMV) Seronegative Blood Products for the Prevention of Transfusion-Associated CMV Infection After Marrow Transplant

Blood, 1995-11, Vol.86 (9), p.3598-3603, Article 3598

1995

Volltextzugriff (PDF)

Sensitive detection of human cytomegalovirus peptide–specific cytotoxic T-lymphocyte responses by interferon-γ–enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation

Blood, 2002-05, Vol.99 (10), p.3830-3837

2002

Volltextzugriff (PDF)

Cellular therapy with sequential unmanipulated donor lymphocyte infusions in drug-resistant cytomegalovirus (CMV) encephalitis

Blood, 2011-05, Vol.117 (21), p.5772-5774

2011

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTransplantation Proceedings

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)
Japanisch
(20)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation—a randomized double-blind placebo-controlled study

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells

Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy

CMV: a warrior against leukemia?

Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation : Effect of patient age and donor leukocyte infusions

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

Cytomegalovirus pp65 Antigenemia-Guided Early Treatment With Ganciclovir Versus Ganciclovir at Engraftment After Allogeneic Marrow Transplantation: A Randomized Double-Blind Study

Pharmacotherapy versus T lymphocytes for CMV

Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants

Antiviral cell therapy: is this the future?

Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening

A Comparison of Filtered Leukocyte-Reduced and Cytomegalovirus (CMV) Seronegative Blood Products for the Prevention of Transfusion-Associated CMV Infection After Marrow Transplant

Sensitive detection of human cytomegalovirus peptide–specific cytotoxic T-lymphocyte responses by interferon-γ–enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation

Cellular therapy with sequential unmanipulated donor lymphocyte infusions in drug-resistant cytomegalovirus (CMV) encephalitis

Aktive Filter

Suchergebnisse filtern